• The relationships of visceral and subcutaneous fat with cardiometabolic risk factors and insulin resistance have been well described in adults.
Summary
The aim of this study was to evaluate the association of abdominal visceral and subcutaneous fat, independent of total body fat, with cardiometabolic risk factors and insulin resistance among youth. Visceral and subcutaneous fat, percentage total body fat, insulin resistance (adjusted for lean body mass: Mlbm), blood pressure, glucose, insulin and lipids were obtained in 472 youth ages 6-18 years. Linear regression, adjusted for age, sex, race, Tanner stage and percentage total body fat, was used to evaluate associations of visceral and subcutaneous fat with cardiometabolic risk factors. Visceral fat was associated inversely with Mlbm (P = 0.003) and positively with fasting insulin (P = 0.002) and triglycerides (P = 0.002). Visceral fat levels above the mean were associated inversely with high-density lipoprotein (HDL) cholesterol (P = 0.002), and positively with systolic blood pressure (P < 0.0001) and non-HDL cholesterol (P < 0.0001). Subcutaneous fat was associated inversely with Mlbm (P = 0.003) and HDL cholesterol (P < 0.05), and positively with fasting glucose (P < 0.05), fasting insulin (P = 0.0003), systolic blood pressure (P = 0.005) and triglycerides (P = 0.003). Subcutaneous fat levels above the mean were associated with non-HDL cholesterol (P = 0.0002). These findings suggest that there may be a threshold level of visceral and subcutaneous fat (regardless of total body fat), that when exceeded in childhood, is more likely to be associated with many cardiometabolic risk factors. Triglycerides and insulin resistance appear to be associated with these fat depots at even lower thresholds of abdominal adiposity.
Introduction
Compared with what is known in adults, the relationship of abdominal adiposity with cardiometabolic risk factors and insulin resistance among children and adolescents is incompletely understood. Paediatric studies have reported an association between abdominal visceral fat, quantified using imaging-based measurement techniques such as magnetic resonance imaging or computed tomography (CT), and fasting insulin (1-3), insulin secretion (4), insulin resistance (3, 4) , impaired glucose tolerance (5), triglycerides (1-3), low levels of high-density lipoprotein (HDL) cholesterol (1), components of the metabolic syndrome (1, 3, (6) (7) (8) (9) , low levels of adiponectin (10) , and oxidative stress (11) . Similarly, abdominal subcutaneous fat has been shown to be correlated with insulin resistance in overweight and obese children (12) . However, questions remain as to the relative contribution of specific fat depots, vs. total body adiposity, to cardiometabolic risk. The issue is important because it has implications regarding early screening for, and identification of, high-risk obesity phenotypes (13) , and to inform potential interventions intended to reduce abdominal adiposity (14) . Therefore, the aim of this cross-sectional study was to evaluate the association of abdominal visceral and subcutaneous fat, independent of percentage total body fat, with cardiometabolic risk factors and insulin resistance among a large cohort of children and adolescents.
Materials and methods

Study design and participants
This cross-sectional study included 472 children and adolescents (of the 557 total subjects, 85 were excluded because Tanner stage was not available) ages 6-18 years old throughout a range of body mass index (BMI) values (normal weight through obese). Data from two separate studies, both of which obtained cardiometabolic risk factors in children and adolescents and utilized the same data collection methods and procedures, were combined. One was a community-based longitudinal study and the other was a study of childhood cancer survivors and their healthy siblings (the latter group was included in the current study). The respective study protocols were approved by the University of Minnesota Institutional Review Board and consent/assent was obtained from parents/participants.
Anthropometric, body fat and blood pressure measurements
Participants arrived for testing at the University of Minnesota Clinical and Translational Science Institute after an overnight 10-12-hour fast. Tanner stage was determined by trained paediatricians according to pubic hair development in boys, and breast and pubic hair development in girls, with the most mature value used to define pubertal status. Weight and height were measured on a calibrated electronic scale and stadiometer, respectively, with light clothes and without shoes. BMI was calculated as weight in kilograms divided by height in meters squared. Waist circumference was measured to the nearest 0.5 cm, taken in duplicate, and the mean value was used in the analysis. Percentage total body fat was measured by dual energy X-ray absorptiometry (DXA) (Lunar Prodigy, General Electric Medical Systems, Madison, WI, USA) and analysed using its enCore TM software (platform version 10.5.). Abdominal visceral and subcutaneous fat was obtained by CT using a Siemens Sensation 16 (Siemens Medical Solutions, Malvern, PA, USA) with two separate slices obtained at the L4-L5 interspace. The two images were subdivided into five-mm slices and the first and third five-mm slices were combined and analysed for visceral adipose tissue. The upper limit of adipose tissue density was −30 Hounsfield units (HU) and the lower limit was −190 HU. The average of two blood pressure measurements from the right arm of rested, seated subjects was used in analyses.
Measurement of insulin resistance and lipids
Insulin resistance was measured in those 10 years of age and older by the euglycaemic insulin clamp as previously described (15) . Insulin was infused at a constant rate of 1 mU kg −1 min −1 for 3 h, and glucose was infused at a variable rate to maintain euglycaemia. Insulin resistance (M) was expressed as the glucose infusion rate (mg kg 
Statistical analysis
Linear regression analysis, adjusted for age, sex, race, Tanner stage and percentage total body fat, was used to evaluate associations of visceral and subcutaneous fat (included in separate models) with cardiometabolic risk factors and Mlbm, independent of percentage total body fat. Generalized estimating equations, with robust standard errors, were used to account for sibling relationships. In exploratory analyses, certain risk factors were associated with the fat measures in a slightly complicated manner.
Specifically, instead of a straight line (linear) association, the association followed a straight line with one bend in it; in particular, a straight line with a change in the line's slope at the mean of the fat measure. Thus, for all of the risk factors except triglycerides, insulin, and Mlbm, in analyses, including the fat variables, each fat variable was entered linearly with a change in slope at the mean. Subgroup analyses were done by sex and Tanner stage (I, II-IV and V) for descriptive purposes only. For each outcome measure, visceral and subcutaneous fat were compared according to the amount of variation in the outcome that each explained independently of percentage total body fat and the other adjusters. One thousand bootstrap samples of families were drawn (preserving clustering by family); each bootstrap sample was analysed as above but ignoring clustering, and a two-sided P value was computed by inverting the bootstrap confidence interval for (R 2 including visceral fat) minus (R 2 including subcutaneous fat). To evaluate whether visceral fat, subcutaneous fat and percentage total body fat were associated with the cardiometabolic risk factors and Mlbm independently of BMI percentile, waist circumference percentile, and waistto-height ratio (which addresses whether the more complex and expensive direct measures of body fat provide additional information regarding cardiometabolic risk beyond these conventional anthropometric measures), we estimated separate linear regression models, each adjusted for these three conventional measures All analyses were done using the SAS system (v. 9.2; SAS Institute, Cary, NC, USA). All P values are two-sided, and <0.05 is considered statistically significant.
Results
Demographics
Data from 472 children and adolescents (including 95 family units) ages 6-18 years old (246 boys, 226 girls, mean age 12.3 ± 3.7) were included. Demographic data and mean levels of cardiometabolic risk factors and insulin resistance are shown in Table 1 . Associations of visceral and subcutaneous fat with cardiometabolic risk factors
Results of the linear regression analysis evaluating associations of visceral and subcutaneous fat with cardiometabolic risk factors and Mlbm are shown in Table 2 . Visceral fat was associated inversely with Mlbm (P = 0.003) and positively with fasting insulin (P = 0.002), HOMA-IR (P < 0.05), and triglycerides (P = 0.002). Visceral fat levels above the mean were associated inversely with HDL cholesterol (P = 0.002), and positively with HOMA-IR (P = 0.0002), systolic blood pressure (P < 0.0001), and non-HDL cholesterol (P < 0.0001). Subcutaneous fat was associated inversely with Mlbm (P = 0.003) and HDL cholesterol (P < 0.05), and positively with fasting glucose (P < 0.05), fasting insulin (P = 0.0003), HOMA-IR (P = 0.0003), systolic blood pressure (P = 0.005), and triglycerides (P = 0.003). Subcutaneous fat levels above the mean were associated with HOMA-IR (P < 0.0001) and non-HDL cholesterol (P = 0.0002). Analyses were also performed using systolic blood pressure percentile and the conclusions were the same; therefore, only results with absolute systolic blood pressure are reported, above.
Results by sex
Among boys, visceral fat was associated with triglycerides (P = 0.005). Subcutaneous fat was associated with fasting insulin (P = 0.004), HOMA-IR (P < 0.05), systolic blood pressure (P < 0.05) and triglycerides (P = 0.005). Among girls, visceral fat was inversely associated with Mlbm (P = 0.0006) and HDL cholesterol (P < 0.05), and positively associated with fasting glucose (P = 0.005), fasting insulin (P < 0.05), HOMA-IR (P = 0.004), and triglycerides (P < 0.05). Subcutaneous fat was inversely associated with Mlbm (P < 0.05) and HDL cholesterol (P < 0.05), and positively associated with fasting insulin (P < 0.05), HOMA-IR (P < 0.05), and systolic blood pressure (P < 0.05).
Results by Tanner stage
Within Tanner stage I (pre-puberty), visceral fat was associated with triglycerides (P = 0.008). Subcutaneous fat was inversely associated with Mlbm (P < 0.05) and non-HDL cholesterol (P < 0.05), and positively associated with HOMA-IR (P = 0.006). Within Tanner stages II-IV (puberty), visceral fat was associated with fasting insulin (P < 0.05) and triglycerides (P < 0.05). Subcutaneous fat was associated with fasting insulin (P < 0.05). Within Tanner stage V (post-puberty), subcutaneous fat was associated with fasting insulin (P < 0.05) and triglycerides (P < 0.05).
Associations among body fat measurements
There was a high degree of co-linearity between the abdominal fat measures and the other measures of body fatness. Abdominal visceral fat was significantly correlated with percentage total body fat (r = 0.68), BMI percentile (r = 0.56), waist circumference percentile (r = 0.58) and waist-to-height ratio (r = 0.59), all P < 0.0001. Similarly, abdominal subcutaneous fat was significantly correlated with percentage total body fat (r = 0.85), BMI percentile (r = 0.65), waist circumference percentile (r = 0.65) and waist-to-height ratio (r = 0.73), all P < 0.0001.
Results adjusting for clinical anthropometric measurements
Results of the separate linear regression model, adjusted for BMI percentile, waist circumference percentile and waistto-height ratio, demonstrated that visceral, subcutaneous, and percentage total body fat were significantly associated with fasting insulin (all P < 0.001) and triglycerides (all P < 0.05), but were not associated with blood pressure, cholesterol or Mlbm. Visceral and subcutaneous fat were associated with HOMA-IR (both P < 0.05). Only visceral fat was associated with fasting glucose (P < 0.05).
Relative strength of associations -visceral vs. subcutaneous fat
Results of the analysis comparing visceral vs. subcutaneous fat according to the strength of their respective associations with the cardiometabolic risk factors found no statistically significant differences. In other words, neither fat depot appeared to be superior to the other in the strength of its relationship with cardiometabolic risk factors, after accounting for percentage total body fat.
Discussion
The primary finding of this study is that the visceral and the subcutaneous depots of the abdominal fat region, independent of percentage total body adiposity, appear to have similar associations with many cardiometabolic risk factors and insulin resistance as early as the first two decades of life. The relationships of visceral and subcutaneous fat with many of these risk factors were stronger among children and adolescents who had levels of these respective fat depots at or above the mean, whereas the relationship of these fat depots with triglycerides and insulin resistance tended to be present throughout their entire range of values. These findings suggest that there may be a threshold level of visceral and subcutaneous fat that, when exceeded, is more likely to be associated with cardiometabolic risk factors. Triglycerides and insulin resistance appear to be associated with these fat depots at even lower thresholds of abdominal adiposity. Results of this study have implications for both screening for, and treatment of, childhood obesity. In relation to screening, children and adolescents with high levels of abdominal visceral and subcutaneous fat may be at the highest risk for developing later cardiovascular disease and type 2 diabetes. Interventions that target the abdominal fat depot may be effective in terms of reducing risk of these chronic diseases.
The findings of the current study are in agreement with results from a number of other paediatric studies that have reported associations of visceral fat with various cardiometabolic risk factors, insulin resistance and oxidative stress (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . Our data confirm the previous findings within the context of a relatively large sample of children and adolescents and provide additional evidence suggesting that the abdominal subcutaneous fat depot is also associated with multiple cardiometabolic risk factors and insulin resistance. This has important screening implications because total abdominal adiposity is relatively easily measured in the clinic setting through simple waist measurement, while visceral adiposity alone requires more sophisticated and expensive techniques.
Our observations show some differences compared with two previous studies reporting that total body fat (17) and subcutaneous fat (12) were more strongly associated with insulin resistance than visceral fat. In the current study, after adjustment for percentage total body fat, visceral and subcutaneous fat remained independently associated with insulin resistance. The reasons for the disparate findings may be related to the larger sample size in the current study, the use of a sensitive measure of insulin resistance (euglycaemic, hyperinsulinaemic clamp), and/or slight differences in locations used for quantification of the fat depots among the studies.
In an attempt to address a more clinically relevant question, we evaluated whether directly measured visceral, clinical obesity Abdominal Fat and Risk Factors in Youth A. S. Kelly et al. 105 subcutaneous and percentage total body fat were associated with cardiometabolic risk factors and insulin resistance, independent of various surrogate adiposity measures that can be easily obtained in the clinical setting such as BMI, waist circumference and waist-to-height ratio. When adjustments were made for these standard anthropometric variables, many of the associations among the measures of body fat and risk factors disappeared. However, this is not surprising because of the relatively high degree of co-linearity among many of these anthropometric measures with adiposity (i.e. BMI, waist circumference and waistto-height ratio are surrogate measures of body fat). Therefore, these results suggest that many of the standard anthropometric techniques used to estimate body fat in the clinic can serve as reasonable surrogates for abdominal adiposity.
Strengths of the current study included the relatively large sample size, the wide age range of the participants, and the use of well-validated and accurate techniques to measure insulin resistance (euglycaemic, hyperinsulinaemic clamp) and visceral/subcutaneous fat (CT). It should be noted that when CT is used to measure visceral and subcutaneous fat depots, the values obtained may not be representative of the total volume of adiposity in these areas because only a limited number of slices can be obtained (in our study between the L4-L5 interspace). The crosssectional nature of the study did not allow for any inferences regarding whether visceral or subcutaneous fat play a causal role in the development of cardiometabolic risk factors or insulin resistance. Longitudinal studies will be needed in order to shed light on this question.
In conclusion, results of the current study, which utilized a relatively large sample size and included direct measures of abdominal visceral and subcutaneous fat and insulin resistance, provide evidence that the visceral and subcutaneous depots of the abdominal fat region, independent of percentage total body adiposity, appear to have similar associations with many cardiometabolic risk factors and insulin resistance early in life. Relationships of visceral and subcutaneous fat with many of the risk factors were stronger among individuals with levels of these respective fat depots at or above the mean. However, the relationships of these fat depots with triglycerides and insulin resistance existed throughout their entire range of values. These findings suggest that there may be a threshold level of visceral and/or subcutaneous fat that when exceeded, regardless of total body adiposity level, place these youth at increased risk of developing cardiovascular disease and type 2 diabetes later in life compared with those with lower levels of abdominal fat. Perhaps interventions targeting reductions in centrally located adiposity will have the largest impact on improving cardiometabolic risk factors among obese children and adolescents.
